These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 32124682)
1. Potential treatment of Parkinson's disease with omega-3 polyunsaturated fatty acids. Li P; Song C Nutr Neurosci; 2022 Jan; 25(1):180-191. PubMed ID: 32124682 [TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effect of omega-3 polyunsaturated fatty acids in the 6-OHDA model of Parkinson's disease is mediated by a reduction of inducible nitric oxide synthase. Mori MA; Delattre AM; Carabelli B; Pudell C; Bortolanza M; Staziaki PV; Visentainer JV; Montanher PF; Del Bel EA; Ferraz AC Nutr Neurosci; 2018 Jun; 21(5):341-351. PubMed ID: 28221817 [TBL] [Abstract][Full Text] [Related]
3. Omega-3 polyunsaturated fatty acids and Parkinson's disease: A systematic review of animal studies. Alves BDS; Schimith LE; da Cunha AB; Dora CL; Hort MA J Neurochem; 2024 Aug; 168(8):1655-1683. PubMed ID: 38923542 [TBL] [Abstract][Full Text] [Related]
4. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease. Zhang W; Wang T; Pei Z; Miller DS; Wu X; Block ML; Wilson B; Zhang W; Zhou Y; Hong JS; Zhang J FASEB J; 2005 Apr; 19(6):533-42. PubMed ID: 15791003 [TBL] [Abstract][Full Text] [Related]
5. Lycopodium Attenuates Loss of Dopaminergic Neurons by Suppressing Oxidative Stress and Neuroinflammation in a Rat Model of Parkinson's Disease. Jayaraj RL; Beiram R; Azimullah S; Meeran MFN; Ojha SK; Adem A; Jalal FY Molecules; 2019 Jun; 24(11):. PubMed ID: 31185705 [TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of n-3 polyunsaturated fatty acids administration in a partial lesion model of Parkinson's disease: The role of glia and NRf2 regulation. Hernando S; Requejo C; Herran E; Ruiz-Ortega JA; Morera-Herreras T; Lafuente JV; Ugedo L; Gainza E; Pedraz JL; Igartua M; Hernandez RM Neurobiol Dis; 2019 Jan; 121():252-262. PubMed ID: 30296616 [TBL] [Abstract][Full Text] [Related]
7. Dietary eicosapentaenoic acid normalizes hippocampal omega-3 and 6 polyunsaturated fatty acid profile, attenuates glial activation and regulates BDNF function in a rodent model of neuroinflammation induced by central interleukin-1β administration. Dong Y; Xu M; Kalueff AV; Song C Eur J Nutr; 2018 Aug; 57(5):1781-1791. PubMed ID: 28523372 [TBL] [Abstract][Full Text] [Related]
8. Omega-3 polyunsaturated fatty acids ameliorate neuroinflammation and mitigate ischemic stroke damage through interactions with astrocytes and microglia. Zendedel A; Habib P; Dang J; Lammerding L; Hoffmann S; Beyer C; Slowik A J Neuroimmunol; 2015 Jan; 278():200-11. PubMed ID: 25468770 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration. Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665 [TBL] [Abstract][Full Text] [Related]
10. Omega-3 polyunsaturated fatty acid attenuates the inflammatory response by modulating microglia polarization through SIRT1-mediated deacetylation of the HMGB1/NF-κB pathway following experimental traumatic brain injury. Chen X; Chen C; Fan S; Wu S; Yang F; Fang Z; Fu H; Li Y J Neuroinflammation; 2018 Apr; 15(1):116. PubMed ID: 29678169 [TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of Astilbin on MPTP-induced Parkinson's disease mice: Glial reaction, α-synuclein expression and oxidative stress. Zhu YL; Sun MF; Jia XB; Cheng K; Xu YD; Zhou ZL; Zhang PH; Qiao CM; Cui C; Chen X; Yang XS; Shen YQ Int Immunopharmacol; 2019 Jan; 66():19-27. PubMed ID: 30419450 [TBL] [Abstract][Full Text] [Related]
15. Impact of ω-3 fatty acids in Parkinson's disease. Bousquet M; Calon F; Cicchetti F Ageing Res Rev; 2011 Sep; 10(4):453-63. PubMed ID: 21414422 [TBL] [Abstract][Full Text] [Related]
16. FK506 reduces neuroinflammation and dopaminergic neurodegeneration in an α-synuclein-based rat model for Parkinson's disease. Van der Perren A; Macchi F; Toelen J; Carlon MS; Maris M; de Loor H; Kuypers DR; Gijsbers R; Van den Haute C; Debyser Z; Baekelandt V Neurobiol Aging; 2015 Mar; 36(3):1559-68. PubMed ID: 25660193 [TBL] [Abstract][Full Text] [Related]
17. Pathomechanism Characterization and Potential Therapeutics Identification for Parkinson's Disease Targeting Neuroinflammation. Chen CM; Yen CY; Chen WL; Lin CH; Wu YR; Chang KH; Lee-Chen GJ Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494411 [TBL] [Abstract][Full Text] [Related]
18. Maternal Omega-3 Supplement Improves Dopaminergic System in Pre- and Postnatal Inflammation-Induced Neurotoxicity in Parkinson's Disease Model. Delattre AM; Carabelli B; Mori MA; Kempe PG; Rizzo de Souza LE; Zanata SM; Machado RB; Suchecki D; Andrade da Costa BLS; Lima MMS; Ferraz AC Mol Neurobiol; 2017 Apr; 54(3):2090-2106. PubMed ID: 26924316 [TBL] [Abstract][Full Text] [Related]
19. Human Amniotic Epithelial Cells Alleviate a Mouse Model of Parkinson's Disease Mainly by Neuroprotective, Anti-Oxidative and Anti-Inflammatory Factors. Zhang J; Li H; Yang H; Lin J; Wang Y; Zhang Q; Gao WQ; Xu H J Neuroimmune Pharmacol; 2021 Sep; 16(3):620-633. PubMed ID: 33164162 [TBL] [Abstract][Full Text] [Related]